Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-12

Study Completion Date

2024-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to To study the blood bioavailability of a sustained-release β-alanine granulated supplement of two different doses (10 g and 20 g).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety Analysis of Chronic Intake of a β-alanine Supplement

NCT05334121

Product Safety

COMPLETED NA

Study to Analyze the Aerobic Performance Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists

NCT06167395

Beta Alanine Supplementation

COMPLETED NA

The Efficacy β-Alanine Supplementation in Performance Outcomes of Road Professional Endurance Cyclists

NCT04427319

Supplementation Cyclists

COMPLETED NA

Study to Analyze the Efficacy of Acute Intake With a β-alanine Supplement in Recreational Cyclists

NCT06180512

Beta Alanine Supplementation

COMPLETED NA

24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

NCT03655041

Sports Nutritional Physiological Phenomena

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will consume 10 g of β-alanine one day by 4 ingestions of 2.5 g separated by 1 hour and 15 min. While on another day 20 g of β-alanine by 4 ingestions of 5 g separated by 1 hour and 15 minutes, with a washout period of 15 days between the two doses. Subsequently, the amino acid levels in blood will be analyzed after the product intake and during a period of 8 hours.

Each day of visit the paresthesias (moment of appearance, intensity and sensations) will be studied at different times.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bioavailability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low Dose

10 mg of β-alanine

Group Type EXPERIMENTAL

Low dose

Intervention Type DIETARY_SUPPLEMENT

Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 2.5, separated by 1 hour and 15 min.

High Dose

20 mg of β-alanine

Group Type EXPERIMENTAL

High dose

Intervention Type DIETARY_SUPPLEMENT

Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 5 separated by 1 hour and 15 min.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low dose

Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 2.5, separated by 1 hour and 15 min.

Intervention Type DIETARY_SUPPLEMENT

High dose

Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 5 separated by 1 hour and 15 min.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men between 18 and 60 years old.
* Cyclists with more than two years of cycling experience.
* Bicycle training at least twice a week.

Exclusion Criteria

* Suffer a lasting injury that prevents you from training in the month prior to surgery.
* Subjects with a chronic illness.
* Having consumed in the three months prior to the start of the study any β-alanine supplement.
* Making changes in diet or exercise during the study.
* Inability to understand the informed consent form.
* Consumption of other supplements that could alter the results of the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes